Day: November 22, 2019

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

Written by Customer Service on November 22, 2019. Posted in Public Companies.

Company announcement – No. 39 / 2019Zealand Pharma increases its share capital as a consequence of exercise of employee warrantsCopenhagen, November 22, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has increased its share capital by a nominal amount of DKK 158,225 divided into 158,225 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under several of Zealand’s employee warrant programs. Employee warrant programs are part of Zealand’s incentive scheme, and each warrant gives the owner the right to subscribe for one new Zealand share at a pre specified price, the exercise price, in specific predefined time periods before...

Reliq Health Technologies, Inc. Signs Six New Contracts in Texas

Written by Customer Service on November 22, 2019. Posted in Public Companies.

HAMILTON, Ontario, Nov. 22, 2019 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has signed contracts with six new clients in Texas.“We are very pleased to welcome six new clients to Reliq’s iUGO Care platform,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “These six new clients include physician practices, home health agencies, a home hospice organization and a pharmacy network with multiple locations across South Texas. These healthcare organizations will be using the iUGO Care Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) modules, and in some cases the iUGO Home product line...

GW Pharmaceuticals to Present at Upcoming Investor Conferences

Written by Customer Service on November 22, 2019. Posted in Public Companies.

CARLSBAD, Calif., Nov. 22, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc and its U.S. subsidiary Greenwich Biosciences Inc. (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GW’s Chief Executive Officer, will present at two upcoming conferences:Evercore ISI 2nd Annual HealthCONx Conference, on Wednesday, December 4th, 2019 at 10:15 a.m. ESTPiper Jaffray 31st Annual Healthcare Conference on Thursday, December 5th, 2019 at 8:30 a.m. ESTA live audio webcast of the presentations will be available through GW’s corporate website at www.gwpharm.com on the Investors section under Events & Presentations. A replay will be available for each soon after the live presentation.About GW Pharmaceuticals...

Wingstop Appoints Chief Marketing Officer and Senior Vice President of People

Written by Customer Service on November 22, 2019. Posted in Public Companies.

DALLAS, Nov. 22, 2019 (GLOBE NEWSWIRE) — Wingstop Inc. (NASDAQ: WING) today announced the appointment of Christina Clarke as Chief Marketing Officer, previously interim Chief Marketing Officer of Wingstop, and Donnie Upshaw as Senior Vice President of People, previously Vice President of Human Resources. “Cultivating and promoting talent within our organization is a cornerstone of the path toward long-term growth and success at Wingstop,” said Charlie Morrison, Wingstop Chairman and CEO. “Christina has contributed tremendously to our marketing strategy, and Donnie’s extensive expertise in talent management has already proved fruitful to our growing talent base. Both Christina and Donnie embody the leadership qualities that will continue to help us execute against our growth strategy.”Since joining Wingstop in 2018, Christina...

Neovasc Reducer™ Featured During Therapy Development Program in Coburg and Session at Maria Cecilia Hospital in Cotignola

Written by Customer Service on November 22, 2019. Posted in Public Companies.

– Educational events featuring the Reducer hosted in Germany and Italy –VANCOUVER, CA, COBURG, DE, and COTIGNOLA, IT, Nov. 22, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Neovasc Reducer™ (the “Reducer”) was featured during a program hosted in Coburg on Wednesday, November 20, 2019. Additionally, on Friday, November 22, 2019, a distinguished group of physicians will feature the Reducer in a GVM Care & Research Group (the “GVM Group”) dedicated session at the Maria Cecilia Hospital in Cotignola...

Central 1 reports third quarter 2019 financial results

Written by Customer Service on November 22, 2019. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Nov. 22, 2019 (GLOBE NEWSWIRE) — Central 1 Credit Union (Central 1) reported profit after tax of $5.7 million in the third quarter ended September 30, 2019, compared to a very strong third quarter 2018 profit after tax of $19.3 million. Net financial income was $17.8 million compared to $27.3 million in the same period a year ago.Investments in our strategic initiatives continued throughout the third quarter, consistent with our long-term strategy. Wholesale Financial Services continues to deliver on its initiative to expand Central 1’s wholesale products and services across Canada.Development of the Forge Digital Banking Platform (Forge) continues to accelerate. The full Forge retail suite comprising a public website, mobile app and online banking capabilities are now in active use across Canada. First...

Partners Value Investments Inc. Announces Q3 2019 Interim Results

Written by Customer Service on November 22, 2019. Posted in Earnings Releases And Operating Results.

TORONTO, Nov. 22, 2019 (GLOBE NEWSWIRE) — Partners Value Investments Inc. (the “Company”, TSX: PVF.WT) announced today its financial results for the three months ended September 30, 2019. All amounts are stated in US dollars.The Company generated net loss of $35 million for the three months ended September 30, 2019 compared to net loss of $29 million in the prior year period. The decrease in net income was primarily driven by the change in valuation losses and an increase in warrant liability, partially offset by foreign currency gains.The market price of a Brookfield share was $53.09 as at September 30, 2019 (December 31, 2018 – $38.35).Consolidated Statements of Operations

Partners Value Investments L.P. Announces Q3 2019 Interim Results

Written by Customer Service on November 22, 2019. Posted in Earnings Releases And Operating Results.

TORONTO, Nov. 22, 2019 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (the “Partnership” TSX: PVF.UN TSX: PVF.PR.U) announced today its financial results for the three months ended September 30, 2019. All amounts are stated in US dollars.The Partnership had a net income of $14 million for the quarter ended September 30, 2019 compared to a net income of $2 million in the prior year period. The increase in net income was primarily attributable to distributions from underlying investments, foreign currency gains resulting from the strengthening United States dollar, partially offset by lower valuation gains in the current quarter.The Partnership successfully completed its substantial issuer bid, by repurchasing $250 million of its Class A Preferred Limited Partnership units through a wholly owned subsidiary.The market price of...

Sentaida Tire Company Ltd. Elevates OTC Status to “Current Information” and Signs Binding LOI for Reverse Merger with GivBux Global Partners, Inc.

Written by Customer Service on November 22, 2019. Posted in Public Companies.

FULLERTON, CA, Nov. 22, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Sentaida Tire Company, Ltd. (Pink Sheets: SDTC) announced today that the company has been upgraded to OTC “Current Information” status and has also agreed in a Binding Letter of Intent to a reverse merger with GivBux Global Partners, Inc. www.givbux.com. Sentaida has completed all OTC reporting requirements, including the posting of current financials, and all relevant company information is now available on the OTC Markets/Pink Sheets website at http://www.otcmarkets.com.More importantly, Mr. CJ Melone, President of Sentiada Tire Company, confirmed that after a series of long deliberations, the company has agreed to enter into a reverse merger agreement with GivBux Global Partners, Inc. Both parties have signed a Binding Letter of Intent and are expecting to...

Announcement of drawings – Nykredit Realkredit A/S

Written by Customer Service on November 22, 2019. Posted in Public Companies.

To Nasdaq Copenhagen22 November 2019Announcement of drawingsPursuant to s 24 Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes drawings data as at 22 November 2019.Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on nykredit.com/ir.For further information about data format and contents, please refer to the Nasdaq website.Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.Yours sincerelyNykredit Realkredit A/SAttachmentsAnnouncement of drawings – Nykredit Realkredit – 22112019kfdata – 22112019

Day: November 22, 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals